Foghorn Therapeutics Inc. Common Stock FHTX
$4.92
+1.03%
at last close
Analyst Consensus
- Consensus Rating
- Buy (6 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $11.67
- Implied Upside
- +137.1%
- Price Target Range
- $10.00 – $13.00
- Analysts (12 mo)
- 6
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-03-12 | WedbushRobert Driscoll |
Reiterates | Outperform | $10 |
| 2026-03-10 | HC Wainwright & Co.Andres Y. Maldonado |
Reiterates | Buy | $13 |
| 2026-02-17 | JefferiesAmin Makarem |
Maintains | Buy | $14 → $12 |
| 2025-12-18 | BTIGJeet Mukherjee |
Initiates coverage on | Buy | $11 |
| 2025-12-04 | StifelLaura Prendergast |
Initiates coverage on | Buy | $12 |
| 2025-11-07 | GuggenheimMichael Schmidt |
Initiates coverage on | Buy | $12 |
| 2025-05-15 | JMP SecuritiesSilvan Tuerkcan |
Reiterates | Market outperform | $9 |
| 2025-04-30 | JMP SecuritiesSilvan Tuerkcan |
Reiterates | Market outperform | $9 |
| 2025-04-30 | HC Wainwright & Co.Andres Maldonado |
Reiterates | Buy | $13 |
| 2025-04-23 | JMP SecuritiesSilvan Tuerkcan |
Initiates coverage on | Market outperform | $9 |
| 2025-03-07 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $13 |
| 2025-01-30 | B. Riley SecuritiesKalpit Patel |
Initiates coverage on | Buy | $10 |
| 2024-12-17 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $20 → $13 |
| 2024-12-16 | JefferiesKelly Shi |
Maintains | Buy | $18 → $14 |
| 2024-09-24 | Morgan StanleyVikram Purohit |
Maintains | Equal-weight | $6 → $9 |
| 2024-09-03 | JefferiesKelly Shi |
Initiates coverage on | Buy | $18 |
| 2024-08-19 | Evercore ISI GroupGavin Clark-Gartner |
Initiates coverage on | Outperform | $20 |
| 2024-08-12 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $20 |
| 2024-08-09 | WedbushRobert Driscoll |
Reiterates | Outperform | $13 |
| 2024-05-07 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $20 |
| 2024-05-01 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $20 |
| 2024-04-10 | WedbushRobert Driscoll |
Reiterates | Outperform | $13 |
| 2024-04-10 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $20 |
| 2024-03-08 | WedbushRobert Driscoll |
Reiterates | Outperform | $13 |
| 2023-11-13 | Morgan StanleyVikram Purohit |
Maintains | Equal-weight | $10 → $6 |
| 2023-08-07 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $20 |
| 2023-07-06 | Morgan StanleyVikram Purohit |
Maintains | Equal-weight | $13 → $10 |
| 2023-06-29 | Goldman SachsPaul Choi |
Maintains | Buy | $21 → $19 |
| 2023-06-28 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $20 |
| 2023-06-08 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $20 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $4.92
- Market Cap
- $292.18 million
- 52-Week Range
- $3.27 – $7.61
- Average Volume
- 332K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.